Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Norwegian Cruise Line Holdings Ltd (NCLH) vs Tenet Healthcare Corporation (THC) Price & Performance

Norwegian Cruise Line Holdings LtdTrade
Tenet Healthcare CorporationTrade

Price performance (Past 24H)

Key statistics

Norwegian Cruise Line Holdings Ltd vs Tenet Healthcare Corporation — how do they compare? Norwegian Cruise Line Holdings Ltd trades at $15.5 (market cap $7.11B), while Tenet Healthcare Corporation trades at $260 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 3× Norwegian Cruise Line Holdings Ltd's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Norwegian Cruise Line Holdings Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Norwegian Cruise Line Holdings Ltd for 68 Days and Tenet Healthcare Corporation for 15 Days on average.

NCLHTHC
Market Cap
$7.11B$20.98B
Volume
22,683,268428,008
Sector
Consumer CyclicalHealth
52-Week High
$25.02$280.77
52-Week Low
$14.12$161.37
Typical Hold Time
68 Days15 Days
Enterprise Value
$21.93B$32.06B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line Holdings (NCLH) trades at $15.05, down 2.97% on the day, with a neutral technical signal and bearish moving average trend. The company reported strong earnings beats in recent quarters, with Q3 2026 expected to exceed guidance at $0.914 EPS. Fundamentals show robust revenue growth to $9.83B in 2025, though net income margin compressed to 4.3%. Recent news highlights yield pressure and a $950M senior notes offering.

NCLH presents a mixed outlook: valuation appears attractive with a P/E of 9.39 and analyst consensus target of $20.86, implying upside. However, high debt levels, net yield pressures, and volatile cash flows pose risks. The stock offers potential for recovery if operational improvements and pricing strategies stabilize profitability through 2027.

Tenet Healthcare Corporation

Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.

THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NCLH
100% Buy0% Sell
Avg holding period · 68 Days
THC

No sentiment data available yet.

Top news

Latest headlines on both assets

About Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.

Read more on NCLH →

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC →